[en] AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. METHODS AND RESULTS: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. CONCLUSION: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients' management and outcomes and ultimately positively impacting on healthcare resources.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Sannino, Anna; Department of Advanced Biomedical Sciences, Federico II University, Naples,
Campbell, Sarah; Department of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.
Grapsa, Julia ; Department of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.
Modine, Thomas; Service Médico-Chirurgical, Valvulopathies-Chirurgie Cardiaque-Cardiologie
Barbanti, Marco; Ferrarotto Hospital, University of Catania, Catania, Italy.
Chambers, John B; Department of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.
Zamorano, Jose L; Department of Cardiology, Hospital Universitario Ramón y Cajal, M-607, 9, 100,
Pibarot, Philippe; Institut de Cardiologie et de Pneumologie de Québec, Laval University, Québec
Garbi, Madalina; Department of Cardiology, Royal Papworth Hospital, Cambridge Biomedical Campus,
Vannan, Mani; Piedmont Heart Institute, Atlanta, Georgia.
Habib, Gilbert; Cardiology Department, AP-HM, La Timone Hospital, Marseille, France.
Lancellotti, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie ; Cardiology Department, University Hospital Centre, Centre Hospitalier
Language :
English
Title :
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005–1011.
Chen J, Li W, Xiang M. Burden of valvular heart disease, 1990-2017: results from the Global Burden of Disease Study 2017. J Glob Health 2020;10:020404.
Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357: 439–441.
Dooley LM, Ahmad TB, Pandey M, Good MF, Kotiw M. Rheumatic heart disease: a review of the current status of global research activity. Autoimmun Rev 2021;20:102740.
Domenech B, Pomar JL, Prat-Gonzalez S, Vidal B, López-Soto A, Castella M, Sitges M. Valvular heart disease epidemics. J Heart Valve Dis 2016;25:1–7.
Kong WKF, Bax JJ, Michelena HI, Delgado V. Sex differences in bicuspid aortic valve disease. Prog Cardiovasc Dis 2020;63:452–456.
Østergaard L, Oestergaard LB, Lauridsen TK, Dahl A, Chaudry M, Gislason G, Torp-Pedersen C, Bruun NE, Valeur N, Køber L, Fosbøl EL. Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study. Eur J Cardiothorac Surg 2018;54:860–866.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL; ESC Scientific Document Group. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075–3128.
Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Piérard LA, Maurer G. ESC working group on valvular heart disease position paper–heart valve clinics: organization, structure, and experiences. Eur Heart J 2013;34:1597–1606.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL; Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611–644.
Bennett S, Thamman R, Griffiths T, Oxley C, Khan JN, Phan T, Patwala A, Heatlie G, Kwok CS. Mitral annular disjunction: a systematic review of the literature. Echocardiography 2019;36:1549–1558.
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O, Maggioni AP, Lancellotti P; EURO-ENDO Investigators. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 2019;40:3222–3232.
Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P. Standards defining a ‘Heart Valve Centre’: ESC working group on valvular heart disease and European Association for Cardiothoracic Surgery viewpoint. Eur Heart J 2017;38: 2177–2183.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561–632.
Chambers J, Campbell B, Wilson J, Arden C, Ray S. How should specialist competencies in heart valve disease be recognized? QJM 2015;108:353–354.
Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F, Lancellotti P, Mahmoud-Elsayed H, Marsan NA, Maurovich-Hovart P, Monaghan M, Ribeiro J, Sade LE, Swaans M, Von Bardeleben RS, Wunderlich N, Zamorano JL, Popescu BA, Cosyns B, Edvardsen T; Reviewers: This document was reviewed by members of the 2018-2020 EACVI Scientific Documents Committee. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2021;22:471–479.
